Abacus Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Abacus Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 31, 2023	SELL	$0.13 - $76.84 $359 - $212,385	-2,764 Closed	0 $0
Q2 2022 May 31, 2023	BUY	$72.62 - $79.98 $200,721 - $221,064	2,764 New	2,764 $213 Million
Q1 2022 May 31, 2023	SELL	$61.48 - $73.72 $215,856 - $258,830	-3,511 Closed	0 $0
Q4 2021 May 31, 2023	BUY	$53.63 - $62.52 $188,294 - $219,507	3,511 New	3,511 $219 Million
Q3 2021 May 31, 2023	BUY	$59.17 - $69.31 $16,981 - $19,891	287 Added 7.95%	3,899 $231 Million
Q2 2021 May 31, 2023	BUY	$61.91 - $67.42 $223,618 - $243,521	3,612 New	3,612 $241 Million
Q1 2021 May 31, 2023	BUY	$59.34 - $66.74 $201,696 - $226,849	3,399 New	3,399 $215 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Abacus Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Abacus Wealth Partners, LLC with notifications on news.